Latest news and updates

Monthly Market Review: February 2023

Both risk and duration assets sold off in February as pessimism over the monetary policy outlook took hold.

Read more

Monthly Market Review: January 2023

Markets started 2023 on an optimistic note. Equities, bonds and alternatives generally rose. Rates and spreads declined and equity market volatility fell to its lowest level in almost a year.

Read more

Market & Economic Conditions - Q4 2022

The fourth quarter of 2022 began with two strong consecutive months in October and November followed by a selloff in December. Investor optimism seemed to return in October and November.

Read more

Monthly Market Review: December 2022

December was a disappointing end to a bad year for markets. Investors had few places to hide as traditional safe haven assets such as bonds fell in tandem with equities.

Read more

Monthly Market Review - Nov 2022

November saw equities and other growth assets maintain the positive momentum from October.

Read more

Monthly Market Review: October 2022

October saw investor optimism return despite a fragile macro outlook. After two consecutive months of drawdowns across most asset classes, October saw a notable rebound in developed market equities.

Read more

Market & Economic Conditions - Q3 2022

The third quarter of 2022 began with a strong rally in July, however was followed by a moderate decline in August and a broad based selloff in September.

Read more

Monthly Market Review - Sep 2022

September 2022 left few portfolios unscathed in a major drawdown that affected a vast majority of asset classes in public markets.

Read more

Monthly Market Review: August 2022

Shares sold off in the second half of August. Poor economic data and the Federal Reserve reasserting that monetary policy will be tighter for longer were the catalysts for the move downward.

Read more

Monthly Market Review: July 2022

Share markets staged a recovery rally during July despite economic data continuing to deteriorate.

Read more

Market And Economic Conditions : Q2 2022

Markets sold off broadly over the second quarter of 2022. Asset prices were challenged by central bank tightening, economic growth momentum fading and the earnings outlook becoming more challenged.

Read more

Monthly Market Review: June 2022

Equity markets sold off heavily in June after US inflation came in above expectations, which prompted the Federal Reserve to hike its overnight rate by 75 basis points.

Read more

Monthly Market Review: May 2022

After the April sell-off, volatility remained high though developed equity markets stabilized during the second half of May and finished the month relatively flat.

Read more

Monthly Market Review: April 2022

Global equity markets had their worst month since March 2020.


Read more

Market and Economic Conditions : Q1 2022

Over the first quarter of 2022, markets faced challenges stemming from the Russia - Ukraine conflict, higher inflation and volatility leading to significant declines in global equity and bond markets.

Read more

Monthly Market Review: March 2022

Global equity markets recovered in mid-March as sentiment improved somewhat. Central bank tightening and rising yields continued to negatively impact bond markets.

READ MORE

Monthly Market Review - February 2022

February was dominated by the Russian invasion of Ukraine which caused a spike in market volatility and energy prices that rippled across the market.

Read more

Monthly Market Review - January 2022

The start of this year began with a selloff in equities as market volatility spiked over geopolitical concerns and the planned acceleration in monetary tightening as inflation continued to soar.

Read more

Women in Finance Awards 2021

Congratulations to Goldman Sachs & JB Were Superannuation Fund Chair Angela Manning on winning the Director of the Year at the Women in Finance Awards 2021!


Read more

Market and Economic Conditions: Q4 2021

In a high inflationary and high volatility market environment, global equity markets rallied over the fourth quarter and finished the year with strong positive returns.

Read more

Monthly Market Review: December 2021

Concerns over the latest Covid-19 variant quickly dissipated over December.



Read more

Monthly Market Review: November 2021

Over November, risk assets suffered a sell off over inflation, tapering and Covid-19 variant concerns.

Read more

Monthly Market Review: October 2021

Global equity markets regained momentum over October, recovering from the prior month's weak performances.

Read more

Market and Economic Conditions - Q3 2021

Global equity markets suffered a significant sell-off towards the end of the third quarter, following a strong start and initial risk-on tone.

Read more

Monthly Market Review: September 2021

Following months of positive performance, equity markets suffered a global sell-off with September being the first negative month since January 2021.

Read more

Monthly Market Review: August 2021

Over August, the number of cases associated with the COVID-19 delta variant surged, slowing down the global economic recovery as countries with low vaccination rates.

Read more

Monthly Market Review: July 2021

Over July, forward-looking purchasing manager indices revealed that growth in highly vaccinated countries has started to stabilise at high levels.

Read more

Monthly Market Review: Q2 2021

After an initial slow rollout of vaccination programs, developed market shave now made significant progress.

Read more

Monthly Market Review - June 2021

Over June, the US Federal Reserve shifted to more of a hawkish stance as inflation indicators reached decade highs.

Read more

Monthly Market Review: May 2021

Over May, inflation fears intensified as a result of a strong economic growth outlook and ongoing policy support, evidenced by expansionary budget proposals in both the US and Australia.

Read more

Monthly Market Review: April 2021

Global equity markets had a strong month over April, driven by economic optimism, accommodative monetary and fiscal policy and across developed markets the acceleration of vaccination rates.

Read more

GSJBW Superannuation fund news coverage

Goldman Sachs JB Were Superannuation Fund has received some favourable media coverage recently regarding the level of returns members receive:

Read more

Monthly Market Review: Q1 2021

Share markets have maintained broadly positive returns since the December quarter, despite the volatility witnessed in Treasury yields and the slow rollout of vaccination programs globally.

Read more

Monthly Market Review - March 2021

Over March, the US released positive economic data and announced the potential for further government stimulus, which helped strengthen investor sentiment.

Read more

Member Director Election 2021

On behalf of the Trustee Board, a thanks to all those who participated in the Member Director election process whether by nominating a candidate, accepting a nomination, or through casting your ballot

Read more

Monthly Market Review: February 2021

Over the month of February, the economic data that was released showed mixed results and share markets were volatile.

Read more

Monthly Market Review: January 2021

Over the month of January, economic data signalled a short term hit due to pandemic-related restrictions.

Read more

We're #1 for MySuper investment

The Goldman Sachs & JBWere Superannuation Fund is an industry leader for investment performance when compared with all MySuper products over three, five and six years to 30 June 2020!

Read more

Monthly Market Review: Q4 2020

Markets achieved strong positive returns over the December quarter despite the re-imposition of restrictions as a result of a resurgence in COVID-19 cases and the spread of a new strain.

Read more

Monthly Market Review: December 2020

Over the month of December, markets broadly achieved positive returns as vaccine roll-outs and another fiscal stimulus package in the US offset bad news on the virus front.

Read more

Monthly Market Review: November 2020

While COVID-19 cases continued to soar in the US, UK and Continental Europe over November, markets shrugged off short-term developments and soared on the back of positive vaccine news.

Read more

Monthly Market Review: Q3 2020

Markets have maintained a broadly positive run since the previous quarter.

Read more

Monthly Market Review: September 2020

Over the month of September, markets experienced a reversal in investor sentiment.

Read more

Monthly Market Review: August 2020

For the month of August, growth assets performed well as investor momentum remained strong.

Read more

Monthly Market Review: July 2020

The month of July generally saw positive returns across asset classes, as growth assets continue to gain.

Read more

Monthly Market Review: Q2 2020

Markets have recovered over the June quarter from the sharp declines in March.

Read more

Monthly Market Review: June 2020

Growth assets continued to recover over June, but at a slower and more volatile pace than in May.

Read more

Who’ll get your super if you die?

Have you made a binding death benefit nomination? A binding nomination instructs the Fund who to pay your death benefit to if you die.

Read more

Monthly Market Review: May 2020

Following the strong rebound in risk assets over April, the recovery continued into the month of May.

Read more

Monthly Market Review: April 2020

Coronavirus fears drove losses across equity markets and sparked a flight to defensive assets over April.

Read more

Monthly Market Review: Q1 2020

Markets have responded negatively to the rapid spread of the Coronavirus around the world, which was declared a global pandemic by the World Health Organisation.

Read more

Monthly Market Review: March 2020

COVID-19 has continued to spread rapidly around the world and was declared a global pandemic by the World Health Organisation.

Read more

Monthly Market Review: February 2020

Coronavirus fears drove losses across equity markets and sparked a flight to defensive assets over February.

READ more

Monthly Market Review: January 2020

Global Shares closed out the month with losses after reaching fresh highs in mid January 2020.

Read more

Monthly Market Review: Q4 2019

Global share markets ended a remarkable 2019 rally on a strong note with major stock indexes reaching fresh all-time highs

Read more

BEST Superannuation Pty Ltd (ABN 57 070 732 008, AFSL 530672) as trustee of the Goldman Sachs & JBWere Superannuation Fund (ABN 55 697 537 183, SPIN BES0001AU)